×
About 34,540 results

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
https://clinicaltrials.gov/ct2/show/NCT04889430

Sep 30th, 2022 - The study is designed as a multicenter, single-arm, open label study to demonstrate the efficacy and safety of LNP023 (iptacopan) at a dose of 200 mg b.i.d. in adult patients with aHUS who are treatment naive to complement inhibitor therapy (including anti-C5 antibody). The study will enroll approximately 50 participants and assess the effects of iptacopan on a range of efficacy assessments rel...

Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes
https://clinicaltrials.gov/ct2/show/NCT04484363

Sep 30th, 2022 - This is an expanded access program in which the drug being tested is called pevonedistat, which is used in combination with azcitidine. This study will provide expanded access of pevonedistat (in combination with azacitidine) for the first-line treatment to participants with HR-MDS and option of real world data (RWD) collection for the benefit of future participants. All participants will recei...

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
https://clinicaltrials.gov/ct2/show/NCT04496960

Sep 30th, 2022 - Study Description: As a primary objective, this study represents an innovative investigative measure of the safety and tolerability of JAK inhibition in participants with primary Sj(SqrRoot)(Delta)gren's syndrome. Secondary objectives will include investigating the effects of Tofacitinib on target tissues (e.g., salivary glands), systemic inflammation, and on vascular function in SS participant...

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
https://clinicaltrials.gov/ct2/show/NCT04745910

Sep 30th, 2022 - PRIMARY OBJECTIVE: I. To collect preliminary data on the effectiveness of a single dose of pegloticase in lowering serum uric acid levels to less than 6.0 mg/dl within 24 hours in patients with hyperuricemia in the setting of tumor lysis syndrome. SECONDARY OBJECTIVES: I. To assess the effect of pegloticase on renal function in patients with hyperuricemia in the setting of tumor lysis syndrome ...

Pathogenesis of Physical Induced Urticarial Syndromes
https://clinicaltrials.gov/ct2/show/NCT00887939

Sep 30th, 2022 - Urticaria is a common skin disorder that is classified according to its chronicity into acute and chronic forms. It may occur spontaneously or on exposure to a physical factor. In the latter case, the urticaria is classified as a physical urticaria . Physical urticaria may be induced by mechanical and applied pressure, exercise, or exposure to cold, heat, sun, water, or vibration. The urticaria...

Improving Sleep Health in Adults With Overweight or Obesity
https://clinicaltrials.gov/ct2/show/NCT04990206

Sep 30th, 2022 - Aim 1 (Primary): Examine the feasibility and acceptability of TranS-C among adults with poor sleep health and excess weight. Aim 2 (Exploratory): Explore the effect of TranS-C on the sleep health of adults with poor sleep and excess weight. Aim 3 (Exploratory): Explore the effect of TranS-C on the cardiometabolic health of adults with poor sleep and excess weight.

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
https://clinicaltrials.gov/ct2/show/NCT01553461

Sep 30th, 2022 - Principal Investigators: The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers. Study Design: This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications. Primary Objective: The primary objective of this study is to...

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001254

Sep 30th, 2022 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Effects of Peppermint Oil in Cardiometabolic Outcomes in Participants With Metabolic Syndrome
https://clinicaltrials.gov/ct2/show/NCT05561543

Sep 30th, 2022 - Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Previous non-randomized interventions have shown that oral...

Green Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
https://clinicaltrials.gov/ct2/show/NCT05561270

Sep 30th, 2022 - Chronic pain is a major complaint among many individuals living with hEDS and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. A multidisciplinary approach, including pharmacologic and nonpharmacologic pain management, physical therapy, occupational therapy, and psychological trea...

The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome
https://clinicaltrials.gov/ct2/show/NCT05561452

Sep 30th, 2022 - The study is a prospective double-blind randomized placebo-controlled trial. The study population is consisted of patients aged 18-65 years, who applied to the Department of Physical Medicine and Rehabilitation, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey and were diagnosed with rotator cuff tendinopathy and/or partial tear in the supraspinatus tendon (< 50%) by clinical a...

The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause
https://clinicaltrials.gov/ct2/show/NCT05561972

Sep 30th, 2022 - Genitourinary syndrome of menopause (GSM) is a definition including vaginal dryness, burning, vaginal pruritus, dyspareunia and urinary symptoms which can have a negative effect on women's sexuality and quality of life. The most common strategies to overcome GSM are non-hormonal (vaginal lubricants, topical moisturizers, energy-based devices etc.) and hormonal therapies. While vaginal lubricant...

Fenfluramine for Adult Dravet Patients
https://clinicaltrials.gov/ct2/show/NCT05560282

Sep 30th, 2022 - Full Title: Fenfluramine for the treatment of refractory Epilepsy in Adult Dravet patients Short Title: Fenfluramine for Adult Dravet patients Clinical Phase: Phase III Sample Size: A total of 15 participants will be included in the study. Study Population: Adult patients (18 years and older) with drug-resistant epilepsy (maintained on their existing medications, with exception of cannabidiol) ...

Measurement-Based Care Vs. Standard Care for Major Depressive Disorder
https://clinicaltrials.gov/ct2/show/NCT05431374

Sep 30th, 2022 - Hypothesis: The rates of response and remission, and time to response and remission would be significantly shorter in the MBC group, without greater dropout rates and side effect burden, compared with the standard treatment group. Study design and setting This will be a multi-centre, with assessors blind to protocol and treatment group, parallel arm, randomized controlled trial (RCT). The study...

Blood Flow and Blood Pressure Investigation in Down Syndrome
https://clinicaltrials.gov/ct2/show/NCT05528549

Sep 30th, 2022 - Specific Aims Down Syndrome (DS) is the most prevalent genetic form of intellectual disability, and individuals with DS have low work capacity. Reduced work capacity limits gross motor function, and thus, reduces independence, full participation, and ultimately quality of life (QOL). Low work capacity is associated with central autonomic dysfunction in persons with DS, which limits maximal hear...

Defining Neurobiological Links Between Substance Use and Mental Illness
https://clinicaltrials.gov/ct2/show/NCT05538910

Sep 30th, 2022 - Study Description: Tobacco smoking leads to 480,000 deaths and a loss of $300 billion a year in the U.S. Individuals with major depressive disorder (MDD) are more vulnerable for experiencing these burdens as they are twice as likely to use nicotine versus the general population. The current work will explain the neurobiological basis of this enhanced risk and will define potential targets for l...

The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response
https://clinicaltrials.gov/ct2/show/NCT05558488

Sep 30th, 2022 - a) main research assumption Reports in the international literature regarding the importance of the ketogenic diet are ambiguous. Some researchers believe that its use reduces body fat and improves insulin sensitivity or lipid profile, while others question this view and question it. Many authors emphasized the need for further research in this area, and this outline of the research project res...

Characterization and Brain Mechanisms of Frustration in Youth With Severe Irritability or Attention Deficit Hyperactivity Disorder (ADHD)
https://clinicaltrials.gov/ct2/show/NCT05357495

Sep 30th, 2022 - Study Description: Participants in this study will be drawn from those enrolled in Protocol 02-M-0021 or 01-M-0192. This protocol uses detailed clinical phenotyping and a frustration induction task, coupled with pre- and post-frustration resting state scans, to study brain mechanisms mediating severe irritability in youth. The primary objective is to identify brain networks contributing to reco...

Natural History Protocol for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT05413291

Sep 30th, 2022 - Study Description: This is a Natural History and Screening protocol for movement disorders, no research procedures will be done but the resulting data will be used for research. Objectives: Primary Objective: To collect data as part of standard of care evaluation of patients who have or are suspected to have a movement disorder and their family members for use in future secondary research. Endp...

Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD
https://clinicaltrials.gov/ct2/show/NCT05439616

Sep 30th, 2022 - Autism spectrum disorder (ASD) consists of deficits in social, communication, and cognitive development, repetitive and stereotypic behaviors. Many ASD patients show notably high levels of irritability, including verbal and physical aggression, self injury, and/or property destruction. Autistic infants tend to avoid eye contact and show little interest in others. This study will assess how safe...